Skip navigation

Our research in Cardiff

Dr Duncan Baird in the Department of Pathology, University of Wales College of MedicineCardiff is the home of one of our new Cancer Research UK Centres. The Cardiff Centre will help set the pace for national and international progress in genetics and cancer biomarkers. Researchers at the Centre will be focusing on the biology and treatment of bowel, breast and urological cancers and leukaemia. They will also be working on how to make sure cancer is detected earlier.

Cancer Research UK will be increasing its contribution to research in Cardiff by spending an extra £2 million over three years - a massive boost to keep Cardiff leading the way on cancer research in Wales.

Listen to an interview with Professor Alan Clarke, director of the new centre:

Cancer Research UK provides funding for the Wales Cancer Trials Network based in Cardiff. The network provides direct support to 18 hospitals across Wales, and aims to boost the number of people with cancer taking part in clinical trials.

We also fund the clinical trials work of the Children’s Cancer and Leukaemia Group (CCLG) at the Children's Hospital for Wales in Cardiff. The group co-ordinates the care of virtually all the UK’s children with cancer, ensuring they receive the most up-to-date treatments.

Below are some of the highlights of our research in Cardiff.

Bowel cancer

Prof Alan Clarke Prof Alan Clarke

The Genetics Group, School of Biosciences

Cardiff University, Cardiff

Understanding how bowel cancer develops

Professor Alan Clarke at Cardiff University is studying how bowel cancer develops. His research focuses on the role of the APC gene, which is found to be faulty in many cases of bowel cancer. 

Prof Tim Maughan Prof Tim Maughan

Section of Medicine

Cardiff University, Cardiff

Clinical trials in Wales

Tim Maughan is Professor of Cancer Studies in the School of Medicine at Cardiff University. His research focuses on the treatment of people with bowel cancer. He is currently leading a clinical trial called COIN, which is looking at new treatments for bowel cancer that has spread to other parts of the body.

Breast cancer

Prof Glyn Elwyn Prof Glyn Elwyn

School of Medicine

Cardiff University, Cardiff

The digital age of decision-making

Professor Glyn Elwyn at Cardiff University is pioneering the development of 'online decision explorers' for breast and prostate cancer. These tools will help people make difficult decisions relating to cancer diagnosis and treatment. The questions, information and video clips that make up these web-based aids are designed to guide people through the different options available. By helping people to make well-informed choices, they have the potential to relieve anxiety and improve the well-being of people faced with these life-changing situations.

Liver cancer

Prof Trevor Dale Prof Trevor Dale

School of Biosciences

Cardiff University, Cardiff

Studying gene faults involved in liver and bowel cancer

Professor Trevor Dale and his team at the University of Cardiff are investigating faults in important genes that can lead to bowel or liver cancer. By understanding more about these faulty genes, Professor Dale's work is paving the way for new treatments for these diseases.

Lung cancer

Dr Fergus Macbeth Dr Fergus Macbeth

Velindre Hospital

Velindre NHS Trust, Cardiff

Reducing blood clots in lung cancer patients

Dr Fergus Macbeth is an expert in lung cancer research and works at the Velindre Hospital in Cardiff.  He is co-ordinating a clinical trial called FRAGMATIC, investigating whether the blood thinning drug Dalteparin (also called Fragmin) can reduce the number of blood clots in people with lung cancer. Blood clots are common in people with the disease and can also be a side effect of treatment. They can be very serious if they start to move through the body so it is important to find ways of preventing them.

Oesophageal cancer

Dr Tom Crosby Dr Tom Crosby

Velindre Cancer Centre

Velindre NHS Trust, Cardiff

Testing a new way to treat oesophageal cancer

Dr Tom Crosby is a consultant clinical oncologist at the Velindre Hospital in Cardiff. He is running a clinical trial called SCOPE 1, testing a new way of treating oesophageal cancer (cancer of the foodpipe).

Prostate cancer

Prof Glyn Elwyn Prof Glyn Elwyn

School of Medicine

Cardiff University, Cardiff

The digital age of decision-making

Professor Glyn Elwyn at Cardiff University is pioneering the development of 'online decision explorers' for breast and prostate cancer. These tools will help people make difficult decisions relating to cancer diagnosis and treatment. The questions, information and video clips that make up these web-based aids are designed to guide people through the different options available. By helping people to make well-informed choices, they have the potential to relieve anxiety and improve the well-being of people faced with these life-changing situations.